Krebs Biochemicals & Industries

Followers

8
8
5
5
.
1
1
7
7
0.00 (0.00%)

As on 06 Oct, 2025 | 14:46

Open Trading A/c
Day Range
70.30
72.49
LH
52 Week Range
66.12
129.07
LH
Volume
* i
Bid / Ask
0.00
70.70 / 10.00

Krebs Biochemicals & Industries Announcements

The Company has enclosed herewith proceedings of 33rd Annual General Meeting of the Company.

26 Sep, 2025 | 12:47pm • Source: BSE

Krebs Biochemicals and Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

23 Sep, 2025 | 04:40pm • Source: NSE

The Company has enclosed herewith intimation of closure of trading window for quarter and half year ended 30.09.2025

23 Sep, 2025 | 11:01am • Source: BSE

The Company has enclosed herewith RTA Report on re-lodgement of transfer requests of physical shares for the period up to 31.08.2025.

11 Sep, 2025 | 12:17pm • Source: BSE

The Company has enclosed herewith copy of newspapers published in business standard and prajasakti w.r.t. Notice of 33rd Annual General Meeting.

29 Aug, 2025 | 10:49am • Source: BSE

The Company has enclosed herewith notice of 33rd Annual General Meeting of the Company.

28 Aug, 2025 | 02:48pm • Source: BSE

The Company has enclosed herewith copy of Annual Report for the financial year ended 31st March 2025.

28 Aug, 2025 | 12:40pm • Source: BSE

The Company has enclosed herewith copy of newspaper publication of unaudited financial results for the quarter ended 30.06.2025.

08 Aug, 2025 | 12:25pm • Source: BSE

The Company has enclosed herewith comments of Board on fine levied by Exchanges

07 Aug, 2025 | 04:02pm • Source: BSE

Intimation respect to change in management

07 Aug, 2025 | 02:30pm • Source: BSE

result

07 Aug, 2025 | 02:28pm • Source: BSE

Outcome of Board meeting dated 07.08.2025

07 Aug, 2025 | 02:13pm • Source: BSE

The Company has enclosing herewith resignation letter received from Mr. Jitendra Shah Managing Director & CEO

25 Jul, 2025 | 04:00pm • Source: BSE

The Company has enclosed herewith Certificates received from RTA under regulation 7(45) of SEBI DP Regulations, 2018 for the quarter ended 31.06.2025

03 Jul, 2025 | 11:23am • Source: NSE

The Company has enclosed herewith certificates received from RTA under reg. 74(5) of SEBI DP Regulations, 2018 for the quarter ended 31.03.2025

03 Jul, 2025 | 10:41am • Source: BSE

The Company has enclosed herewith intimation for closure of trading window for the quarter ended 30th June 2025.

23 Jun, 2025 | 12:04pm • Source: BSE

The Company has enclosing herewith Annual Secretarial Compline Report for the year ended 31st March 2025.

28 May, 2025 | 03:44pm • Source: BSE

Krebs Biochemicals and Industries Limited has informed the Exchange about Copy of Newspaper Publication

21 May, 2025 | 10:37am • Source: NSE

The Company has enclosing herewith copy of newspaper publication.

21 May, 2025 | 10:28am • Source: BSE

Result for the year ended 31.03.2025

20 May, 2025 | 02:13pm • Source: BSE